Merck · 10 hours ago
Associate Principal Scientist, Clinical Research
Merck is a leading global healthcare company, and they are seeking an Associate Principal Scientist for their Physician Scientist Program. This role provides comprehensive training in pharmaceutical medicine, focusing on clinical trial planning, execution, and regulatory approval processes.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Understand the role and methods of pharmaceutical research, participate in the writing of research protocols, conduct of clinical trials, safety monitoring, analysis of data and communication of study findings
Focus on late-stage and lifecycle drug activities, understand key regulatory policies and the procedures for interacting with health agencies (e.g. FDA); understand key elements in pharmacovigilance, drug safety monitoring, signal detection and processing of adverse reports
Exposure to the management of a product asset prior to, during and after the launch phase (US and Global) including caveats on drug promotion
After a successful first year, the Physician Scientist will be equipped to assume a leading role in the team with additional responsibilities and interactions
Qualification
Required
Candidates must currently hold an MD degree and have completed residency or fellowship training in an accredited US medical program, preferably within the last 5 years
Clinical Development
Clinical Research
Clinical Sciences
Clinical Trial Planning
Clinical Trials
Clinical Trials Monitoring
Communication
Drug Development
Drug Research
Ethical Standards
Good Clinical Practice (GCP)
Medical Research
Medical Writing
Pharmaceutical Research
Pharmacy Regulation
Protocol Development
Regulatory Policies
Research Proposals
Scientific Consulting
Scientific Research
Benefits
Medical
Dental
Vision healthcare and other insurance benefits (for employee and family)
Retirement benefits, including 401(k)
Paid holidays
Vacation
Compassionate and sick days
Company
Merck
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
Funding
Current Stage
Public CompanyTotal Funding
$5.59MKey Investors
Private Capital AdvisorsGavi, the Vaccine Alliance
2018-11-25Post Ipo Equity· $0.59M
2016-01-21Series Unknown· $5M
1980-12-19IPO
Leadership Team
Recent News
2026-01-08
2026-01-08
2026-01-08
Company data provided by crunchbase